Q2 2019 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the BioCryst's Second Quarter 2019 Earnings Call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the call over to John Bluth at BioCryst. Sir, you may begin.
Thank you, Sydney. Good morning and welcome to BioCryst Second Quarter 2019 Corporate Update and Financial Results Conference Call. Today's press release is available on our website. Participating with me today are CEO, Jon Stonehouse; Chief Medical Officer, Dr. Bill Sheridan; CFO, Tom Staab; and Chief Business Officer, Megan Sniecinski. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance and/or achievements. These statements are subject to known and unknown risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |